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ADP-ribosylation of rabbit reticulocyte longation factor 2 (EF-2) catalyzed by the A fragment of diphthe- 
ria toxin leads to a loss of its non-specific affinity for RNA. The removal of the ADP-ribose residue from 
EF-2 in the reverse reaction with nicotinamide restores its affinity for RNA. ADP-ribosylation of EF-2 is 
accompanied by its dissociation from the complexes with mono- and polyribosomes detected in the rabbit 
reticulocyte lysate at low ionic strength. The loss of the non-specific affinity of EF-2 for RNA as a result 
of ADP-ribosylation and, as a consequence, its decompartmentation from polyribosomes is assumed to be 
a reason for the diphtheria toxin-induced inactivation of the factor in eukaryotic cells. 
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1. INTRODUCTION 
It is known that almost all the proteins of the 
eukaryotic translation machinery, including 
aminoacyl-tRNA-synthetases [ 1,2], elongation fac- 
tors [3-61 and most of the initiation factors 
[4,7-g], possess a sufficiently strong non-specific 
affinity for different high molecular mass RNAs, 
i.e., they are RNA-binding proteins. Prokaryotic 
aminoacyl-tRNA-synthetases [l] and the elonga- 
tion factors [6] do not possess uch an affinity. It 
was assumed that the evolutionary acquired RNA- 
binding capability of eukaryotic proteins of the 
translation machinery serves for their compart- 
mentation (local concentration) on the 
polyribosomes to provide for their more efficient 
functioning in the large volume of the eukaryotic 
cell [lo]. 
Indeed, aminoacyl-tRNA-synthetases [ 1 I], 
elongation factors 1 [12] and 2 [13] were found 
among the proteins loosely associated with 
polyribosomes. It has been shown that aminoacyl- 
tRNA-synthetases [14] and EF-1 [12] can be 
displaced from polyribosomes by an excess of ex- 
ogenous RNA, i.e., their association with 
polyribosomes seems to occur due to their non- 
specific RNA-binding capability. 
Modulation of the affinity for RNA of the 
translation machinery proteins could be a means of 
the regulation of protein synthesis in eukaryotic 
cells [2,15]. Some observations may be relevant to 
this assumption. First, eukaryotic aminoacyl- 
tRNA-synthetases for several amino acids exist in 
two forms - the RNA-binding one and that 
without affinity for RNA [2]. Second, 
phosphorylation of RNA-binding proteins can 
change their affinity for RNA [la]. 
One of the best known modifications of the 
translation machinery proteins is ADP- 
ribosylation of elongation factor 2 by diphtheria 
toxin. This modification leads to inhibition of pro- 
tein synthesis [17,18]. The mechanism of such an 
inhibition is not yet known, inasmuch as all the 
partial functions of EF-2 studied are retained after 
its ADP-ribosylation (review [17]). 
Here, we show that ADP-ribosylation of EF-2 is 
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accompanied by a loss of its non-specific affinity 
for high molecular mass RNA and its dissociation 
from the complexes with mono- and 
polyribosomes. 
2. MATERIALS AND METHODS 
The elongation factor 2 with a purity of no less 
than 90% was prepared from rabbit reticulocytes 
as in [19]. The diphtheria toxin was kindly provid- 
ed by Drs Vertiev and Ezepchuk (Gamaleya In- 
stitute of Epidemiology and Microbiology, 
Academy of Medical Sciences of the USSR, 
Moscow). 
The ADP-ribosylation of EF-2 was done using a 
minor modification of the technique in [20]. 
200-X&/r1 samples were incubated with 1-5 pg 
diphtheria toxin and 1 pmol nicotinamide 
[U-14C]adeninedinucleotide (265 pCi/mmol, Am- 
ersham) in 20 mM Tris-HCl buffer (pH 8.3) with 
10 mM DTT for 10 min at 30°C. [14C]ADP- 
ribosyl-elongation factor 2 (ADPR-EF-2) was pre- 
cipitated with 5% trichloroacetic acid and col- 
lected on GF/C (Whatman) filters to count 
radioactivity. 
The de-ADP-ribosylation of EF-2 was per- 
formed by incubating with 1 ,ug diphtheria toxin 
and 20 mM nicotinamide in 50 mM potassium 
acetate buffer, pH 5.2, with 10 mM DTT for 
30 min at 37°C [21]. 
Affinity chromatography of EF-2 on RNA- 
Sepharose 4B (with total Ekcherichia coli rRNA) 
was done as described in [22]. The protein was 
determined by amido black staining technique on 
nitrocellulose filters [22,23]. 
The activity of EF-2 was measured in the 
poly(U)-dependent system of poly-Phe synthesis 
r241. 
The fraction of mono- and polyribosomes of 
rabbit reticulocytes was prepared by gel filtration 
of mitochondria-free extract through a Sephacryl 
S-300 column (Pharmacia). 
3. RESULTS 
When the EF-2 preparation is applied to the 
RNA-Sepharose column both the protein material 
and EF-2 activity are completely adsorbed on the 
column at low ibnic strength and eluted with 1 M 




Fig.1. Chromatography of EF-2 (A), [14C]ADP- 
ribosylated EF-2 (B) and EF-2 after de-ADP- 
ribosylation (C) on the RNA-Sepharose column. The 
preparation of EF-2 in the buffer containing 10 mM 
Tris-HCI (PH 7.6), 10 mM KCl, 0.2 mM EDTA, 7 mM 
@-mercaptoethanol and 10% glycerol was applied onto 
the RNA-Sepharose column, equilibrated with the same 
buffer. The protein adsorbed was eluted with 1 M KC1 
buffer solution. 
observations on the affinity of EF-2 for RNA 141. 
After ADP-ribosylation EF-2 loses its non- 
specific affinity for RNA and is not adsorbed on 
RNA-Sepharose (fig. 1B). 
Incubation of [14C]ADPR-EF-2 with nicotina- 
mide in conditions of de-ADP-ribosylation restores 
activity of the factor and its capability to be ad- 
sorbed on RNA-Sepharose (fig.lC). The small 
amount of the protein that has passed through the 
column without being adsorbed, in this case may 
represent diphtheria toxin or [14C]ADPR-EF-2 
which has not undergone demodification. 
It can be concluded that ADP-ribosylation of 
elongation factor 2 results in a loss of its transla- 
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tion activity and a simultaneous loss of its non- 
specific affinity for RNA, whereas demodifkation 
restores both functions. 
In subsequent experiments we studied the effect 
of ADP-ribosylation on the association of en- 
dogenous EF-2 with mono- and polyribosomes in 
rabbit reticulocyte extracts. Mono- and 
polyribosomes were separated from free proteins 
by gel filtration of the mitochondria-free extract 
through Sephacryl S-300. It turned out that about 
60% of EF-2 passes through Sephacryl together 
with mono- and polyribosomes if Sephacryl is 
equilibrated with a buffer of low ionic strength 
(preparation no.1). If Sephacryl is equilibrated 
with a buffer containing 150 mM KCl, only 
lo-15070 of EF-2 is detected in the fraction of 
mono- and polyribosomes (preparation no.2). 
Centrifugation of the preparations of mono- and 
polyribosomes in the sucrose gradient prepared in 
a buffer without KC1 has demonstrated that about 
a half of EF-2 of preparation no. 1 sediments in the 
zone of mono- and polyribosomes (fig2A). All 
EF-2 of preparation no.2 is found to be associated 
with monoribosomes (fig.2B). 
The addition of an excess of exogenous RNA (E. 
coli 16 S rRNA) to the preparation of mono- and 
polyribosomes before centrifugation shifts all EF-2 
from polyribosomes to the post-polyribosomal 
zone. At the same time, the factor remains 
associated with monoribosomes (fig.%C,D). 
From the above results it can be concluded that 
a significant portion of EF-2 in the rabbit 
reticulocyte extract is associated with mono- and 
polyribosomes. Complexes of EF-2 with 
polyribosomes are labile and reversible, but they 
can be stabilized by lowering the ionic strength of 
the solution. Complexes of EF-2 with 
monoribosomes are sufficiently more stable. The 
loose association of EF-2 with polyribosomes may 
be explained by the interaction of its RNA-binding 
center with the RNA of polyribosomes. 
Fig.2E,F shows the sedimentation distribution 
of EF-2 in mono- and polyribosome preparations 
after its ADP-ribosylation. It is seen that ADP- 
ribosylation of EF-2 in such preparations leads to 
a dissociation of the factor from complexes both 
with poly- and monoribosomes. 
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Fig.2. Sedimentation distribution of EF-2 upon sucrose 
gradient centrifugation of the fraction of mono- and 
polyribosomes. The preparation of mono- and 
polyribosomes was isolated by gel filtration through 
Sephacryl S-300 equilibrated with a buffer without KC1 
(10 mM Tris-HCl, (pH 7.6), 1 mM MgC12) (A,C,E), or 
with the same buffer containing 150 mM KC1 (B,D,F). 
A,B, the mono/polyribosome fraction as such was 
layered on sucrose gradient; C,D, 20 A260 units of E. 
coli 16 S RNA was added to the mono/polyribosome 
fraction before centrifugation; A-D, the EF-2 
distribution was traced by the reaction of ADP- 
ribosylation with J14C]NAD after centrifugation; E,F, 
the mono/polyribosome fraction was [14C]ADP- 
ribosylated before centrifugation and then layered on 
sucrose gradient. Centrifugation was performed in 
1%33.5% sucrose gradient in the buffer without KCl, 
SW-41 rotor, 40000 rpm, 45 min (Spinco L5-50). 
4. DISCUSSION 
Up to the present it is unclear how ADP- 
ribosylation of EF-2 disengages protein synthesis. 
A comparison of intact and ADP-ribosylated EF-2 
in partial reactions, occurring in the process of 
translocation, has shown that the ADP-ribosylated 
factor binds with GTP [25,26], forms an 
408 
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EF-2 - GTP - ribosome complex [26,27] and 
possesses GTPase activity in such a complex 
[28,29]. Finally, ADP-ribosylated EF-2 can, in 
principle, perform translocation when it is added 
to ribosomes in stoichiometric amounts [30]. 
On the other hand, as far back as 1971, authors 
in [3] mentioned that ADP-ribosylation of EF-2 
leads to a loss of its affinity for RNA. However, 
no experimental data validating this conclusion 
were given and no subsequent publications devoted 
to the inactivation mechanism of EF-2 as a result 
of ADP-ribosylation discussed this fact. 
Our results have shown that ADP-ribosylation 
of EF-2 indeed leads to a loss of its non-specific af- 
finity for RNA, and to its release from complexes 
with poly- and monoribosomes. The non-specific 
RNA-binding capability seems to be the only func- 
tion of EF-2 which is known by now to be definite- 
ly lost in response to ADP-ribosylation. 
From the results obtained the RNA-binding 
capability of EF-2 can be assumed to serve for its 
interaction with the exposed regions of 
polyribosomal RNA (mRNA and/or rRNA) and 
the formation of loose complexes, thus leading to 
a local concentration of the factor near the sites of 
translation, i.e., to its partial compartmentation 
on polyribosomes. ADP-ribosylation of EF-2, in- 
ducing the loss of its non-specific affinity for 
RNA, leads to its dilution throughout the volume 
of the cytoplasm, i.e., to its decompartmentation. 
The drastic decrease of the effective concentration 
of the factor near polyribosomes may result in an 
abrupt drop of the protein synthesis rate. Anyhow, 
the proposed mechanism of protein synthesis in- 
hibition, as a result of ADP-ribosylation of EF-2, 
does not contradict the available experimental 
facts. 
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